APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Cancer Chemotherapy Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Blood Cancer Chemotherapy Drugs Industry Growth and Trends Forecast to 2032

23 December 2025129 pages

Choose your research edition.

Industry ResearchBlood Cancer Chemotherapy Drugs Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Cancer Chemotherapy Drugs Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Blood Cancer Chemotherapy Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Cancer Chemotherapy Drugs Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Cancer Chemotherapy Drugs Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Blood Cancer Chemotherapy Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Blood Cancer Chemotherapy Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Blood Cancer Chemotherapy Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood Cancer Chemotherapy Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Blood Cancer Chemotherapy Drugs include CHIA TAI Tianqing Pharmaceutical, Hisunpharm, Takeda, Shenzhen Main Luck Pharmaceuticals, Sanofi, Johnson And Johnson, Novartis, Merck and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Blood Cancer Chemotherapy Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Blood Cancer Chemotherapy Drugs market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Blood Cancer Chemotherapy Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Blood Cancer Chemotherapy Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Blood Cancer Chemotherapy Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Blood Cancer Chemotherapy Drugs Market by Company

CHIA TAI Tianqing Pharmaceutical

Hisunpharm

Takeda

Shenzhen Main Luck Pharmaceuticals

Sanofi

Johnson And Johnson

Novartis

Merck

Roche

Lunan Pharmaceutical Group

Eli Lilly

Gilead Sciences

Pfizer

Hainan Periwinkle Pharmaceutical

Amgen

AbbVie

AstraZeneca

Regeneron Pharmaceuticals

Celgene

BristolMyers Squibb

Blood Cancer Chemotherapy Drugs Segment by Type

Plant Based Anti-Tumor Drugs

Alkylating Agents

Antitumor Antibiotics

Anti Metabolic Drugs

Others

Blood Cancer Chemotherapy Drugs Segment by Application

Lymphoma

Multiple Myeloma

Leukemia

Other Blood Tumors

Blood Cancer Chemotherapy Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Cancer Chemotherapy Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Cancer Chemotherapy Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Cancer Chemotherapy Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Blood Cancer Chemotherapy Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Blood Cancer Chemotherapy Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Plant Based Anti-Tumor Drugs Table 2. Major Company of Alkylating Agents Table 3. Major Company of Antitumor Antibiotics Table 4. Major Company of Anti Metabolic Drugs Table 5. Major Company of Others Table 6. Global Blood Cancer Chemotherapy Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Blood Cancer Chemotherapy Drugs Sales by Type (2021-2026) & (units) Table 8. Global Blood Cancer Chemotherapy Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Blood Cancer Chemotherapy Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Blood Cancer Chemotherapy Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Blood Cancer Chemotherapy Drugs Price by Type (2021-2026) & (USD/unit) Table 12. Global Blood Cancer Chemotherapy Drugs Sales by Type (2027-2032) & (units) Table 13. Global Blood Cancer Chemotherapy Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Blood Cancer Chemotherapy Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Blood Cancer Chemotherapy Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Blood Cancer Chemotherapy Drugs Price by Type (2027-2032) & (USD/unit) Table 17. North America Blood Cancer Chemotherapy Drugs Sales by Type (2021-2026) & (units) Table 18. North America Blood Cancer Chemotherapy Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Blood Cancer Chemotherapy Drugs Sales by Type (2021-2026) & (units) Table 20. Europe Blood Cancer Chemotherapy Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Blood Cancer Chemotherapy Drugs Sales by Type (2021-2026) & (units) Table 22. Asia-Pacific Blood Cancer Chemotherapy Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Blood Cancer Chemotherapy Drugs Sales by Type (2021-2026) & (units) Table 24. Latin America Blood Cancer Chemotherapy Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Blood Cancer Chemotherapy Drugs Sales by Type (2021-2026) & (units) Table 26. Middle East and Africa Blood Cancer Chemotherapy Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Blood Cancer Chemotherapy Drugs Industry Trends Table 28. Blood Cancer Chemotherapy Drugs Industry Drivers Table 29. Blood Cancer Chemotherapy Drugs Industry Opportunities and Challenges Table 30. Blood Cancer Chemotherapy Drugs Industry Restraints Table 31. Global Blood Cancer Chemotherapy Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Blood Cancer Chemotherapy Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Blood Cancer Chemotherapy Drugs Sales by Company (2021-2026) & (units) Table 34. Global Blood Cancer Chemotherapy Drugs Sales Share by Company (2021-2026) Table 35. Global Blood Cancer Chemotherapy Drugs Market Price by Company (2021-2026) & (USD/unit) Table 36. Global Blood Cancer Chemotherapy Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Blood Cancer Chemotherapy Drugs Major Company Production Sites and Headquarters Table 38. Global Blood Cancer Chemotherapy Drugs Company, Product Type & Application Table 39. Global Blood Cancer Chemotherapy Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Blood Cancer Chemotherapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Blood Cancer Chemotherapy Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Blood Cancer Chemotherapy Drugs Sales by Region (2021-2026) & (units) Table 44. Global Blood Cancer Chemotherapy Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Blood Cancer Chemotherapy Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Blood Cancer Chemotherapy Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Blood Cancer Chemotherapy Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 48. Global Blood Cancer Chemotherapy Drugs Sales by Region (2027-2032) & (units) Table 49. Global Blood Cancer Chemotherapy Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Blood Cancer Chemotherapy Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Blood Cancer Chemotherapy Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Blood Cancer Chemotherapy Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 53. Global Blood Cancer Chemotherapy Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Blood Cancer Chemotherapy Drugs Sales by Application (2021-2026) & (units) Table 55. Global Blood Cancer Chemotherapy Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Blood Cancer Chemotherapy Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Blood Cancer Chemotherapy Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Blood Cancer Chemotherapy Drugs Price by Application (2021-2026) & (USD/unit) Table 59. Global Blood Cancer Chemotherapy Drugs Sales by Application (2027-2032) & (units) Table 60. Global Blood Cancer Chemotherapy Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Blood Cancer Chemotherapy Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Blood Cancer Chemotherapy Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Blood Cancer Chemotherapy Drugs Price by Application (2027-2032) & (USD/unit) Table 64. North America Blood Cancer Chemotherapy Drugs Sales by Application (2021-2026) & (units) Table 65. North America Blood Cancer Chemotherapy Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Blood Cancer Chemotherapy Drugs Sales by Application (2021-2026) & (units) Table 67. Europe Blood Cancer Chemotherapy Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Blood Cancer Chemotherapy Drugs Sales by Application (2021-2026) & (units) Table 69. Asia-Pacific Blood Cancer Chemotherapy Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Blood Cancer Chemotherapy Drugs Sales by Application (2021-2026) & (units) Table 71. Latin America Blood Cancer Chemotherapy Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Blood Cancer Chemotherapy Drugs Sales by Application (2021-2026) & (units) Table 73. Middle East and Africa Blood Cancer Chemotherapy Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. CHIA TAI Tianqing Pharmaceutical Company Information Table 75. CHIA TAI Tianqing Pharmaceutical Business Overview Table 76. CHIA TAI Tianqing Pharmaceutical Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. CHIA TAI Tianqing Pharmaceutical Blood Cancer Chemotherapy Drugs Product Portfolio Table 78. CHIA TAI Tianqing Pharmaceutical Recent Development Table 79. Hisunpharm Company Information Table 80. Hisunpharm Business Overview Table 81. Hisunpharm Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Hisunpharm Blood Cancer Chemotherapy Drugs Product Portfolio Table 83. Hisunpharm Recent Development Table 84. Takeda Company Information Table 85. Takeda Business Overview Table 86. Takeda Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Takeda Blood Cancer Chemotherapy Drugs Product Portfolio Table 88. Takeda Recent Development Table 89. Shenzhen Main Luck Pharmaceuticals Company Information Table 90. Shenzhen Main Luck Pharmaceuticals Business Overview Table 91. Shenzhen Main Luck Pharmaceuticals Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Shenzhen Main Luck Pharmaceuticals Blood Cancer Chemotherapy Drugs Product Portfolio Table 93. Shenzhen Main Luck Pharmaceuticals Recent Development Table 94. Sanofi Company Information Table 95. Sanofi Business Overview Table 96. Sanofi Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Sanofi Blood Cancer Chemotherapy Drugs Product Portfolio Table 98. Sanofi Recent Development Table 99. Johnson And Johnson Company Information Table 100. Johnson And Johnson Business Overview Table 101. Johnson And Johnson Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Johnson And Johnson Blood Cancer Chemotherapy Drugs Product Portfolio Table 103. Johnson And Johnson Recent Development Table 104. Novartis Company Information Table 105. Novartis Business Overview Table 106. Novartis Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Novartis Blood Cancer Chemotherapy Drugs Product Portfolio Table 108. Novartis Recent Development Table 109. Merck Company Information Table 110. Merck Business Overview Table 111. Merck Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Merck Blood Cancer Chemotherapy Drugs Product Portfolio Table 113. Merck Recent Development Table 114. Roche Company Information Table 115. Roche Business Overview Table 116. Roche Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Roche Blood Cancer Chemotherapy Drugs Product Portfolio Table 118. Roche Recent Development Table 119. Lunan Pharmaceutical Group Company Information Table 120. Lunan Pharmaceutical Group Business Overview Table 121. Lunan Pharmaceutical Group Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Lunan Pharmaceutical Group Blood Cancer Chemotherapy Drugs Product Portfolio Table 123. Lunan Pharmaceutical Group Recent Development Table 124. Eli Lilly Company Information Table 125. Eli Lilly Business Overview Table 126. Eli Lilly Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Eli Lilly Blood Cancer Chemotherapy Drugs Product Portfolio Table 128. Eli Lilly Recent Development Table 129. Gilead Sciences Company Information Table 130. Gilead Sciences Business Overview Table 131. Gilead Sciences Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Gilead Sciences Blood Cancer Chemotherapy Drugs Product Portfolio Table 133. Gilead Sciences Recent Development Table 134. Pfizer Company Information Table 135. Pfizer Business Overview Table 136. Pfizer Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Pfizer Blood Cancer Chemotherapy Drugs Product Portfolio Table 138. Pfizer Recent Development Table 139. Hainan Periwinkle Pharmaceutical Company Information Table 140. Hainan Periwinkle Pharmaceutical Business Overview Table 141. Hainan Periwinkle Pharmaceutical Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. Hainan Periwinkle Pharmaceutical Blood Cancer Chemotherapy Drugs Product Portfolio Table 143. Hainan Periwinkle Pharmaceutical Recent Development Table 144. Amgen Company Information Table 145. Amgen Business Overview Table 146. Amgen Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. Amgen Blood Cancer Chemotherapy Drugs Product Portfolio Table 148. Amgen Recent Development Table 149. AbbVie Company Information Table 150. AbbVie Business Overview Table 151. AbbVie Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. AbbVie Blood Cancer Chemotherapy Drugs Product Portfolio Table 153. AbbVie Recent Development Table 154. AstraZeneca Company Information Table 155. AstraZeneca Business Overview Table 156. AstraZeneca Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. AstraZeneca Blood Cancer Chemotherapy Drugs Product Portfolio Table 158. AstraZeneca Recent Development Table 159. Regeneron Pharmaceuticals Company Information Table 160. Regeneron Pharmaceuticals Business Overview Table 161. Regeneron Pharmaceuticals Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. Regeneron Pharmaceuticals Blood Cancer Chemotherapy Drugs Product Portfolio Table 163. Regeneron Pharmaceuticals Recent Development Table 164. Celgene Company Information Table 165. Celgene Business Overview Table 166. Celgene Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 167. Celgene Blood Cancer Chemotherapy Drugs Product Portfolio Table 168. Celgene Recent Development Table 169. BristolMyers Squibb Company Information Table 170. BristolMyers Squibb Business Overview Table 171. BristolMyers Squibb Blood Cancer Chemotherapy Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 172. BristolMyers Squibb Blood Cancer Chemotherapy Drugs Product Portfolio Table 173. BristolMyers Squibb Recent Development Table 174. North America Blood Cancer Chemotherapy Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 175. North America Blood Cancer Chemotherapy Drugs Sales by Country (2021-2026) & (units) Table 176. North America Blood Cancer Chemotherapy Drugs Sales Market Share by Country (2021-2026) Table 177. North America Blood Cancer Chemotherapy Drugs Sales Forecast by Country (2027-2032) & (units) Table 178. North America Blood Cancer Chemotherapy Drugs Sales Market Share Forecast by Country (2027-2032) Table 179. North America Blood Cancer Chemotherapy Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. North America Blood Cancer Chemotherapy Drugs Market Size by Country (2021-2026) & (US$ Million) Table 181. North America Blood Cancer Chemotherapy Drugs Market Share by Country (2021-2026) Table 182. North America Blood Cancer Chemotherapy Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. North America Blood Cancer Chemotherapy Drugs Market Share Forecast by Country (2027-2032) Table 184. Europe Blood Cancer Chemotherapy Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 185. Europe Blood Cancer Chemotherapy Drugs Sales by Country (2021-2026) & (units) Table 186. Europe Blood Cancer Chemotherapy Drugs Sales Market Share by Country (2021-2026) Table 187. Europe Blood Cancer Chemotherapy Drugs Sales Forecast by Country (2027-2032) & (units) Table 188. Europe Blood Cancer Chemotherapy Drugs Sales Market Share Forecast by Country (2027-2032) Table 189. Europe Blood Cancer Chemotherapy Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Europe Blood Cancer Chemotherapy Drugs Market Size by Country (2021-2026) & (US$ Million) Table 191. Europe Blood Cancer Chemotherapy Drugs Market Share by Country (2021-2026) Table 192. Europe Blood Cancer Chemotherapy Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Europe Blood Cancer Chemotherapy Drugs Market Share Forecast by Country (2027-2032) Table 194. Asia-Pacific Blood Cancer Chemotherapy Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 195. Asia-Pacific Blood Cancer Chemotherapy Drugs Sales by Country (2021-2026) & (units) Table 196. Asia-Pacific Blood Cancer Chemotherapy Drugs Sales Market Share by Country (2021-2026) Table 197. Asia-Pacific Blood Cancer Chemotherapy Drugs Sales Forecast by Country (2027-2032) & (units) Table 198. Asia-Pacific Blood Cancer Chemotherapy Drugs Sales Market Share Forecast by Country (2027-2032) Table 199. Asia-Pacific Blood Cancer Chemotherapy Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 200. Asia-Pacific Blood Cancer Chemotherapy Drugs Market Size by Country (2021-2026) & (US$ Million) Table 201. Asia-Pacific Blood Cancer Chemotherapy Drugs Market Share by Country (2021-2026) Table 202. Asia-Pacific Blood Cancer Chemotherapy Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 203. Asia-Pacific Blood Cancer Chemotherapy Drugs Market Share Forecast by Country (2027-2032) Table 204. Latin America Blood Cancer Chemotherapy Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 205. Latin America Blood Cancer Chemotherapy Drugs Sales by Country (2021-2026) & (units) Table 206. Latin America Blood Cancer Chemotherapy Drugs Sales Market Share by Country (2021-2026) Table 207. Latin America Blood Cancer Chemotherapy Drugs Sales Forecast by Country (2027-2032) & (units) Table 208. Latin America Blood Cancer Chemotherapy Drugs Sales Market Share Forecast by Country (2027-2032) Table 209. Latin America Blood Cancer Chemotherapy Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 210. Latin America Blood Cancer Chemotherapy Drugs Market Size by Country (2021-2026) & (US$ Million) Table 211. Latin America Blood Cancer Chemotherapy Drugs Market Share by Country (2021-2026) Table 212. Latin America Blood Cancer Chemotherapy Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 213. Latin America Blood Cancer Chemotherapy Drugs Market Share Forecast by Country (2027-2032) Table 214. Middle East and Africa Blood Cancer Chemotherapy Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 215. Middle East and Africa Blood Cancer Chemotherapy Drugs Sales by Country (2021-2026) & (units) Table 216. Middle East and Africa Blood Cancer Chemotherapy Drugs Sales Market Share by Country (2021-2026) Table 217. Middle East and Africa Blood Cancer Chemotherapy Drugs Sales Forecast by Country (2027-2032) & (units) Table 218. Middle East and Africa Blood Cancer Chemotherapy Drugs Sales Market Share Forecast by Country (2027-2032) Table 219. Middle East and Africa Blood Cancer Chemotherapy Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 220. Middle East and Africa Blood Cancer Chemotherapy Drugs Market Size by Country (2021-2026) & (US$ Million) Table 221. Middle East and Africa Blood Cancer Chemotherapy Drugs Market Share by Country (2021-2026) Table 222. Middle East and Africa Blood Cancer Chemotherapy Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 223. Middle East and Africa Blood Cancer Chemotherapy Drugs Market Share Forecast by Country (2027-2032) Table 224. Key Raw Materials Table 225. Raw Materials Key Suppliers Table 226. Blood Cancer Chemotherapy Drugs Distributors List Table 227. Blood Cancer Chemotherapy Drugs Customers List Table 228. Research Programs/Design for This Report Table 229. Authors List of This Report Table 230. Secondary Sources Table 231. Primary Sources List of Figures Figure 1. Blood Cancer Chemotherapy Drugs Image Figure 2. Global Blood Cancer Chemotherapy Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Cancer Chemotherapy Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Blood Cancer Chemotherapy Drugs Sales (2021-2032) & (units) Figure 5. Plant Based Anti-Tumor Drugs Image Figure 6. Global Plant Based Anti-Tumor Drugs Sales YoY Growth (2021-2032) & (units) Figure 7. Alkylating Agents Image Figure 8. Global Alkylating Agents Sales YoY Growth (2021-2032) & (units) Figure 9. Antitumor Antibiotics Image Figure 10. Global Antitumor Antibiotics Sales YoY Growth (2021-2032) & (units) Figure 11. Anti Metabolic Drugs Image Figure 12. Global Anti Metabolic Drugs Sales YoY Growth (2021-2032) & (units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (units) Figure 15. Global Blood Cancer Chemotherapy Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Blood Cancer Chemotherapy Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Blood Cancer Chemotherapy Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Blood Cancer Chemotherapy Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Blood Cancer Chemotherapy Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Blood Cancer Chemotherapy Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Blood Cancer Chemotherapy Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Blood Cancer Chemotherapy Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Blood Cancer Chemotherapy Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Blood Cancer Chemotherapy Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Blood Cancer Chemotherapy Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Blood Cancer Chemotherapy Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Blood Cancer Chemotherapy Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Lymphoma Image Figure 30. Global Lymphoma Sales YoY Growth (2021-2032) & (units) Figure 31. Multiple Myeloma Image Figure 32. Global Multiple Myeloma Sales YoY Growth (2021-2032) & (units) Figure 33. Leukemia Image Figure 34. Global Leukemia Sales YoY Growth (2021-2032) & (units) Figure 35. Other Blood Tumors Image Figure 36. Global Other Blood Tumors Sales YoY Growth (2021-2032) & (units) Figure 37. Global Blood Cancer Chemotherapy Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Blood Cancer Chemotherapy Drugs Market Share by Application 2025 VS 2032 Figure 39. North America Blood Cancer Chemotherapy Drugs Sales Market Share in Volume by Application in 2025 Figure 40. North America Blood Cancer Chemotherapy Drugs Sales Market Share in Value by Application in 2025 Figure 41. Europe Blood Cancer Chemotherapy Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Europe Blood Cancer Chemotherapy Drugs Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Blood Cancer Chemotherapy Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Blood Cancer Chemotherapy Drugs Sales Market Share in Value by Application in 2025 Figure 45. Latin America Blood Cancer Chemotherapy Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Blood Cancer Chemotherapy Drugs Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Blood Cancer Chemotherapy Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Blood Cancer Chemotherapy Drugs Sales Market Share in Value by Application in 2025 Figure 49. North America Blood Cancer Chemotherapy Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 50. North America Blood Cancer Chemotherapy Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Blood Cancer Chemotherapy Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Blood Cancer Chemotherapy Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Blood Cancer Chemotherapy Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 54. Europe Blood Cancer Chemotherapy Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Blood Cancer Chemotherapy Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Blood Cancer Chemotherapy Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Blood Cancer Chemotherapy Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 58. Asia-Pacific Blood Cancer Chemotherapy Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Blood Cancer Chemotherapy Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Blood Cancer Chemotherapy Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Blood Cancer Chemotherapy Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 62. Latin America Blood Cancer Chemotherapy Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Blood Cancer Chemotherapy Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Blood Cancer Chemotherapy Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Blood Cancer Chemotherapy Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 66. Middle East and Africa Blood Cancer Chemotherapy Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Blood Cancer Chemotherapy Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Blood Cancer Chemotherapy Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Blood Cancer Chemotherapy Drugs Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Blood Cancer Chemotherapy Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Plant Based Anti-Tumor Drugs
  • Alkylating Agents
  • Antitumor Antibiotics
  • Anti Metabolic Drugs
  • Others
Applications
  • Lymphoma
  • Multiple Myeloma
  • Leukemia
  • Other Blood Tumors
Companies covered
  • CHIA TAI Tianqing Pharmaceutical
  • Hisunpharm
  • Takeda
  • Shenzhen Main Luck Pharmaceuticals
  • Sanofi
  • Johnson And Johnson
  • Novartis
  • Merck
  • Roche
  • Lunan Pharmaceutical Group
  • Eli Lilly
  • Gilead Sciences
  • Pfizer
  • Hainan Periwinkle Pharmaceutical
  • Amgen
  • AbbVie
  • AstraZeneca
  • Regeneron Pharmaceuticals
  • Celgene
  • BristolMyers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Blood Cancer Chemotherapy Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Blood Cancer Chemotherapy Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Blood Cancer Chemotherapy Drugs Market by Type
  6. 1.3.1 Plant Based Anti-Tumor Drugs
  7. 1.3.2 Alkylating Agents
  8. 1.3.3 Antitumor Antibiotics
  9. 1.3.4 Anti Metabolic Drugs
  10. 1.3.5 Others
  11. 1.4 Global Blood Cancer Chemotherapy Drugs Market Size by Type
  12. 1.4.1 Global Blood Cancer Chemotherapy Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Blood Cancer Chemotherapy Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Blood Cancer Chemotherapy Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Blood Cancer Chemotherapy Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Blood Cancer Chemotherapy Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Blood Cancer Chemotherapy Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Blood Cancer Chemotherapy Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Blood Cancer Chemotherapy Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Blood Cancer Chemotherapy Drugs Industry Trends
  2. 2.2 Blood Cancer Chemotherapy Drugs Industry Drivers
  3. 2.3 Blood Cancer Chemotherapy Drugs Industry Opportunities and Challenges
  4. 2.4 Blood Cancer Chemotherapy Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Blood Cancer Chemotherapy Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Blood Cancer Chemotherapy Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Blood Cancer Chemotherapy Drugs Price (2021-2026)
  4. 3.4 Global Blood Cancer Chemotherapy Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Blood Cancer Chemotherapy Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Blood Cancer Chemotherapy Drugs Company, Product Type & Application
  7. 3.7 Global Blood Cancer Chemotherapy Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Blood Cancer Chemotherapy Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Blood Cancer Chemotherapy Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Blood Cancer Chemotherapy Drugs Tier 1, Tier 2, and Tier 3
4 Blood Cancer Chemotherapy Drugs Regional Status and Outlook
  1. 4.1 Global Blood Cancer Chemotherapy Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Blood Cancer Chemotherapy Drugs Historic Market Size by Region
  3. 4.2.1 Global Blood Cancer Chemotherapy Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Blood Cancer Chemotherapy Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Blood Cancer Chemotherapy Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Blood Cancer Chemotherapy Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Blood Cancer Chemotherapy Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Blood Cancer Chemotherapy Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Blood Cancer Chemotherapy Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Blood Cancer Chemotherapy Drugs by Application
  1. 5.1 Blood Cancer Chemotherapy Drugs Market by Application
  2. 5.1.1 Lymphoma
  3. 5.1.2 Multiple Myeloma
  4. 5.1.3 Leukemia
  5. 5.1.4 Other Blood Tumors
  6. 5.2 Global Blood Cancer Chemotherapy Drugs Market Size by Application
  7. 5.2.1 Global Blood Cancer Chemotherapy Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Blood Cancer Chemotherapy Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Blood Cancer Chemotherapy Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Blood Cancer Chemotherapy Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Blood Cancer Chemotherapy Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Blood Cancer Chemotherapy Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Blood Cancer Chemotherapy Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Blood Cancer Chemotherapy Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CHIA TAI Tianqing Pharmaceutical
  2. 6.1.1 CHIA TAI Tianqing Pharmaceutical Company Information
  3. 6.1.2 CHIA TAI Tianqing Pharmaceutical Business Overview
  4. 6.1.3 CHIA TAI Tianqing Pharmaceutical Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CHIA TAI Tianqing Pharmaceutical Blood Cancer Chemotherapy Drugs Product Portfolio
  6. 6.1.5 CHIA TAI Tianqing Pharmaceutical Recent Developments
  7. 6.2 Hisunpharm
  8. 6.2.1 Hisunpharm Company Information
  9. 6.2.2 Hisunpharm Business Overview
  10. 6.2.3 Hisunpharm Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Hisunpharm Blood Cancer Chemotherapy Drugs Product Portfolio
  12. 6.2.5 Hisunpharm Recent Developments
  13. 6.3 Takeda
  14. 6.3.1 Takeda Company Information
  15. 6.3.2 Takeda Business Overview
  16. 6.3.3 Takeda Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Takeda Blood Cancer Chemotherapy Drugs Product Portfolio
  18. 6.3.5 Takeda Recent Developments
  19. 6.4 Shenzhen Main Luck Pharmaceuticals
  20. 6.4.1 Shenzhen Main Luck Pharmaceuticals Company Information
  21. 6.4.2 Shenzhen Main Luck Pharmaceuticals Business Overview
  22. 6.4.3 Shenzhen Main Luck Pharmaceuticals Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shenzhen Main Luck Pharmaceuticals Blood Cancer Chemotherapy Drugs Product Portfolio
  24. 6.4.5 Shenzhen Main Luck Pharmaceuticals Recent Developments
  25. 6.5 Sanofi
  26. 6.5.1 Sanofi Company Information
  27. 6.5.2 Sanofi Business Overview
  28. 6.5.3 Sanofi Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Blood Cancer Chemotherapy Drugs Product Portfolio
  30. 6.5.5 Sanofi Recent Developments
  31. 6.6 Johnson And Johnson
  32. 6.6.1 Johnson And Johnson Company Information
  33. 6.6.2 Johnson And Johnson Business Overview
  34. 6.6.3 Johnson And Johnson Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Johnson And Johnson Blood Cancer Chemotherapy Drugs Product Portfolio
  36. 6.6.5 Johnson And Johnson Recent Developments
  37. 6.7 Novartis
  38. 6.7.1 Novartis Company Information
  39. 6.7.2 Novartis Business Overview
  40. 6.7.3 Novartis Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Novartis Blood Cancer Chemotherapy Drugs Product Portfolio
  42. 6.7.5 Novartis Recent Developments
  43. 6.8 Merck
  44. 6.8.1 Merck Company Information
  45. 6.8.2 Merck Business Overview
  46. 6.8.3 Merck Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merck Blood Cancer Chemotherapy Drugs Product Portfolio
  48. 6.8.5 Merck Recent Developments
  49. 6.9 Roche
  50. 6.9.1 Roche Company Information
  51. 6.9.2 Roche Business Overview
  52. 6.9.3 Roche Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Roche Blood Cancer Chemotherapy Drugs Product Portfolio
  54. 6.9.5 Roche Recent Developments
  55. 6.10 Lunan Pharmaceutical Group
  56. 6.10.1 Lunan Pharmaceutical Group Company Information
  57. 6.10.2 Lunan Pharmaceutical Group Business Overview
  58. 6.10.3 Lunan Pharmaceutical Group Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Lunan Pharmaceutical Group Blood Cancer Chemotherapy Drugs Product Portfolio
  60. 6.10.5 Lunan Pharmaceutical Group Recent Developments
  61. 6.11 Eli Lilly
  62. 6.11.1 Eli Lilly Company Information
  63. 6.11.2 Eli Lilly Business Overview
  64. 6.11.3 Eli Lilly Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Eli Lilly Blood Cancer Chemotherapy Drugs Product Portfolio
  66. 6.11.5 Eli Lilly Recent Developments
  67. 6.12 Gilead Sciences
  68. 6.12.1 Gilead Sciences Company Information
  69. 6.12.2 Gilead Sciences Business Overview
  70. 6.12.3 Gilead Sciences Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Gilead Sciences Blood Cancer Chemotherapy Drugs Product Portfolio
  72. 6.12.5 Gilead Sciences Recent Developments
  73. 6.13 Pfizer
  74. 6.13.1 Pfizer Company Information
  75. 6.13.2 Pfizer Business Overview
  76. 6.13.3 Pfizer Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Pfizer Blood Cancer Chemotherapy Drugs Product Portfolio
  78. 6.13.5 Pfizer Recent Developments
  79. 6.14 Hainan Periwinkle Pharmaceutical
  80. 6.14.1 Hainan Periwinkle Pharmaceutical Company Information
  81. 6.14.2 Hainan Periwinkle Pharmaceutical Business Overview
  82. 6.14.3 Hainan Periwinkle Pharmaceutical Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Hainan Periwinkle Pharmaceutical Blood Cancer Chemotherapy Drugs Product Portfolio
  84. 6.14.5 Hainan Periwinkle Pharmaceutical Recent Developments
  85. 6.15 Amgen
  86. 6.15.1 Amgen Company Information
  87. 6.15.2 Amgen Business Overview
  88. 6.15.3 Amgen Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Amgen Blood Cancer Chemotherapy Drugs Product Portfolio
  90. 6.15.5 Amgen Recent Developments
  91. 6.16 AbbVie
  92. 6.16.1 AbbVie Company Information
  93. 6.16.2 AbbVie Business Overview
  94. 6.16.3 AbbVie Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 AbbVie Blood Cancer Chemotherapy Drugs Product Portfolio
  96. 6.16.5 AbbVie Recent Developments
  97. 6.17 AstraZeneca
  98. 6.17.1 AstraZeneca Company Information
  99. 6.17.2 AstraZeneca Business Overview
  100. 6.17.3 AstraZeneca Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 AstraZeneca Blood Cancer Chemotherapy Drugs Product Portfolio
  102. 6.17.5 AstraZeneca Recent Developments
  103. 6.18 Regeneron Pharmaceuticals
  104. 6.18.1 Regeneron Pharmaceuticals Company Information
  105. 6.18.2 Regeneron Pharmaceuticals Business Overview
  106. 6.18.3 Regeneron Pharmaceuticals Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Regeneron Pharmaceuticals Blood Cancer Chemotherapy Drugs Product Portfolio
  108. 6.18.5 Regeneron Pharmaceuticals Recent Developments
  109. 6.19 Celgene
  110. 6.19.1 Celgene Company Information
  111. 6.19.2 Celgene Business Overview
  112. 6.19.3 Celgene Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Celgene Blood Cancer Chemotherapy Drugs Product Portfolio
  114. 6.19.5 Celgene Recent Developments
  115. 6.20 BristolMyers Squibb
  116. 6.20.1 BristolMyers Squibb Company Information
  117. 6.20.2 BristolMyers Squibb Business Overview
  118. 6.20.3 BristolMyers Squibb Blood Cancer Chemotherapy Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 BristolMyers Squibb Blood Cancer Chemotherapy Drugs Product Portfolio
  120. 6.20.5 BristolMyers Squibb Recent Developments
7 North America by Country
  1. 7.1 North America Blood Cancer Chemotherapy Drugs Sales by Country
  2. 7.1.1 North America Blood Cancer Chemotherapy Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Blood Cancer Chemotherapy Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Blood Cancer Chemotherapy Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Blood Cancer Chemotherapy Drugs Market Size by Country
  6. 7.2.1 North America Blood Cancer Chemotherapy Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Blood Cancer Chemotherapy Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Blood Cancer Chemotherapy Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Blood Cancer Chemotherapy Drugs Sales by Country
  2. 8.1.1 Europe Blood Cancer Chemotherapy Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Blood Cancer Chemotherapy Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Blood Cancer Chemotherapy Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Blood Cancer Chemotherapy Drugs Market Size by Country
  6. 8.2.1 Europe Blood Cancer Chemotherapy Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Blood Cancer Chemotherapy Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Blood Cancer Chemotherapy Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Blood Cancer Chemotherapy Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Blood Cancer Chemotherapy Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Blood Cancer Chemotherapy Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Blood Cancer Chemotherapy Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Blood Cancer Chemotherapy Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Blood Cancer Chemotherapy Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Blood Cancer Chemotherapy Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Blood Cancer Chemotherapy Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Blood Cancer Chemotherapy Drugs Sales by Country
  2. 10.1.1 South America Blood Cancer Chemotherapy Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Blood Cancer Chemotherapy Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Blood Cancer Chemotherapy Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Blood Cancer Chemotherapy Drugs Market Size by Country
  6. 10.2.1 South America Blood Cancer Chemotherapy Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Blood Cancer Chemotherapy Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Blood Cancer Chemotherapy Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Blood Cancer Chemotherapy Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Blood Cancer Chemotherapy Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Blood Cancer Chemotherapy Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Blood Cancer Chemotherapy Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Blood Cancer Chemotherapy Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Blood Cancer Chemotherapy Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Blood Cancer Chemotherapy Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Blood Cancer Chemotherapy Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Blood Cancer Chemotherapy Drugs Value Chain Analysis
  2. 12.1.1 Blood Cancer Chemotherapy Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Blood Cancer Chemotherapy Drugs Production Mode & Process
  7. 12.2 Blood Cancer Chemotherapy Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Blood Cancer Chemotherapy Drugs Distributors
  10. 12.2.3 Blood Cancer Chemotherapy Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst